Jardiance 25 Mg

Jardiance 25 mg – Product Description

Jardiance 25 mg is a prescription oral antidiabetic medication used for the management of type 2 diabetes mellitus. It contains Empagliflozin 25 mg, which belongs to a class of medicines known as SGLT2 (sodium-glucose co-transporter 2) inhibitors. Jardiance 25 mg helps control blood sugar levels in adults with type 2 diabetes when used alongside a healthy diet, regular exercise, and lifestyle modifications.

In addition to improving glycemic control, Jardiance has demonstrated important cardiovascular and renal benefits, making it a preferred choice for many patients with diabetes who also have heart disease or are at risk of cardiovascular complications. Jardiance 25 mg is often prescribed when lower doses are insufficient to achieve target blood glucose levels.

How Jardiance 25 mg Works

Jardiance 25 mg works by targeting the kidneys rather than the pancreas. It inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this transporter, Jardiance allows excess glucose to be excreted through the urine.

This mechanism lowers blood sugar levels independently of insulin, reducing the risk of hypoglycemia when used alone. Additionally, the loss of glucose through urine leads to mild calorie loss, which may support weight reduction and improved metabolic health. Jardiance also helps reduce blood pressure by promoting mild diuresis.

Uses and Indications

Jardiance 25 mg is prescribed for:

• Type 2 diabetes mellitus in adults

• Patients requiring additional glycemic control beyond diet and exercise

• Diabetes management in combination with other antidiabetic medications, including metformin and insulin

• Reducing the risk of cardiovascular death in adults with type 2 diabetes and established heart disease

• Supporting kidney health in diabetic patients (as advised by a healthcare provider)

It is not intended for use in type 1 diabetes or diabetic ketoacidosis.

Dosage and Administration

Jardiance 25 mg should be taken exactly as prescribed by a healthcare professional. It is usually taken once daily, preferably in the morning, with or without food. The dosage is often started at a lower strength and increased to 25 mg if additional blood sugar control is needed.

Patients should stay well hydrated while taking Jardiance, as increased urination is a common effect of the medication. Regular monitoring of blood glucose levels and kidney function is recommended during treatment.

Safety and Precautions

Jardiance 25 mg is generally well tolerated, but some patients may experience side effects such as increased urination, thirst, urinary tract infections, genital yeast infections, or mild dehydration. Maintaining proper hygiene and adequate fluid intake can help reduce these risks.

Caution is advised in patients with kidney disease, low blood pressure, frequent urinary infections, or dehydration. Rare but serious side effects such as ketoacidosis may occur, even when blood sugar levels are not extremely high. Patients should seek medical attention if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur.

Pregnant and breastfeeding women should use Jardiance only if clearly prescribed by a doctor.

Benefits of Jardiance 25 mg

• Effective blood sugar reduction

• Insulin-independent mechanism of action

• Once-daily convenient dosing

• May support weight loss

• Proven cardiovascular and kidney benefits

• Low risk of hypoglycemia when used alone

Storage Instructions

Store Jardiance 25 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use the medicine after the expiration date printed on the packaging.

External Reference

For detailed medical information about empagliflozin (Jardiance), visit:
https://www.mayoclinic.org/drugs-supplements/empagliflozin-oral-route/description/drg-20113010